1. |
Fan C, Dong Y, Xie Y, et al. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts. Int J Mol Med, 2015, 36(4): 985-991.
|
2. |
Aarabi S, Longaker MT, Gurtner GC. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med, 2007, 4(9): e234.
|
3. |
Lawrence JW, Mason ST, Schomer K, et al. Epidemiology and impact of scarring after burn injury: a systematic review of the literature. J Burn Care Res, 2012, 33(1): 136-146.
|
4. |
陈彬, 首家保, 杨小辉, 等. 口服曲尼司特防治烧伤瘢痕增生的临床研究. 中国美容医学, 2014, 23(3): 173-175.
|
5. |
黎凤明, 许学文, 于蓉, 等. 曲尼司特对大鼠深Ⅱ度烫伤创面愈合及瘢痕形成的作用. 华西药学杂志, 2008, 23(4): 426-428.
|
6. |
Huang D, Shen KH, Wang HG. Pressure therapy upregulates matrix metalloproteinase expression and downregulates collagen expression in hypertrophic scar tissue. Chin Med J (Engl), 2013, 126(17): 3321-3324.
|
7. |
Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Molecular Medicine, 2010, 17(1-2): 113-125.
|
8. |
Liu BH, Chen L, Li SR, et al. Smac/DIABLO regulates the apoptosis of hypertrophic scar fibroblasts. Int J Mol Med, 2013, 32(3): 615-622.
|
9. |
Butzelaar L, Ulrich MM, Mink van der Molen AB, et al. Currently known risk factors for hypertrophic skin scarring: A review. J Plast Reconstr Aesthet Surg, 2016, 69(2): 163-169.
|
10. |
Yin L, Zhao X, Ji S, et al. The use of gene activated matrix to mediate effective SMAD2 gene silencing against hypertrophic scar. Biomaterials, 2014, 35(8): 2488-2498.
|
11. |
Liu J, Wang Y, Pan Q, et al. Wnt/β-catenin pathway forms a negative feedback loop during TGF-β1 induced human normal skin fibroblast-to-myofibroblast transition. J Dermatol Sci, 2012, 65(1): 38-49.
|
12. |
Qiu SS, Dotor J, Hontanilla B. Effect of P144® (Anti-TGF-β) in an "In Vivo” Human Hypertrophic Scar Model in Nude Mice. PLoS One, 2015, 10(12): e0144489.
|
13. |
Wilgus TA, Wulff BC. The Importance of Mast Cells in Dermal Scarring. Adv Wound Care (New Rochelle), 2014, 3(4): 356-365.
|
14. |
Wulff BC, Wilgus TA. Examining the role of mast cells in fetal wound healing using cultured cellsin vitro. Methods Mol Biol, 2013, 1037: 495-506.
|
15. |
Chen L, Schrementi ME, Ranzer MJ, et al. Blockade of mast cell activation reduces cutaneous scar formation. PLoS One, 2014, 9(1): e85226.
|
16. |
冯小倩, 张纲, 张慧宇, 等. 组胺及组胺受体1在大鼠牙周炎发病中表达差异的研究. 牙体牙髓牙周病学杂志, 2015, 25(1): 15-19.
|
17. |
Gutiérrez-Venegas G, Rodriguez-Pérez CE. Toll-like receptor 3 activation promotes desensitization of histamine response in human gingival fibroblasts: Poly (I:C) induces histamine receptor desensitization in human gingival fibroblasts. Cell Immunol, 2012, 273(2): 150-157.
|
18. |
Prud’homme GJ. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest, 2007, 87(11): 1077-1091.
|
19. |
Darakhshan S, Pour AB. Tranilast: a review of its therapeutic application. Pharmacol Res, 2015, 91(10): 15-28.
|